Ray Dalio’s Core Laboratories CLB Stock Holding History

Ray Dalio’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-216,349	Closed	-$11.3M	–	341
2019 Q2	$11.3M	Buy	+216,349	New	+$12.7M	0.09%	102
2017 Q4	–	Sell	-4,417	Closed	-$436K	–	258
2017 Q3	$436K	Buy	+4,417	New	+$428K	﹤0.01%	258
2016 Q3	–	Sell	-7,000	Closed	-$867K	–	322
2016 Q2	$867K	Buy	+7,000	New	+$845K	0.01%	246
2016 Q1	–	Sell	-16,842	Closed	-$1.83M	–	263
2015 Q4	$1.83M	Buy	+16,842	New	+$1.93M	0.02%	190
2015 Q3	–	Sell	-17,448	Closed	-$1.99M	–	445
2015 Q2	$1.99M	Buy	17,448 +15,282	+706%	+$1.85M	0.02%	190
2015 Q1	$226K	Buy	+2,166	New	+$231K	﹤0.01%	303
2014 Q4	–	Sell	-5,949	Closed	-$871K	–	353
2014 Q3	$871K	Buy	+5,949	New	+$918K	0.01%	230

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ray Dalio's CLB Position: Q3 2019 in Review

Ray Dalio sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 216,349 shares — an estimated $11.3M sold.

Ray Dalio first reported a position in CLB in Q3 2014 and held it in 7 quarters. The position peaked at $11.3M in Q2 2019. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Ray Dalio reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
Ray Dalio sold 216,349 Core Laboratories shares in Q3 2019, an estimated $11.3M.
Ray Dalio first reported a position in Core Laboratories in Q3 2014 and held it in 7 quarters.
Ray Dalio's Core Laboratories position peaked at $11.3M in Q2 2019.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Bridgewater Associates's 13F filing for Q3 2019, filed 13 Nov 2019.